4.5 Article

Two-Site Reproducibility of Cerebellar and Brainstem Neurochemical Profiles With Short-Echo, Single-Voxel MRS at 3T

Journal

MAGNETIC RESONANCE IN MEDICINE
Volume 73, Issue 5, Pages 1718-1725

Publisher

WILEY-BLACKWELL
DOI: 10.1002/mrm.25295

Keywords

3 Tesla; multi-site; reproducibility; spectroscopy

Funding

  1. National Institute of Neurological Disorders and Stroke [R01 NS070815]
  2. Assistance Publique des Hopitaux de Paris
  3. program Investissements d'avenir [ANR-10-IAIHU-06]
  4. National Center for Research Resources [P41 RR008079]
  5. National Institute of Biomedical Imaging and Bioengineering [P41 EB015894]
  6. Institutional Center Cores for Advanced Neuroimaging [P30 NS076408]

Ask authors/readers for more resources

PurposeTo determine whether neurochemical concentrations obtained at two MRI sites using clinical 3T scanners can be pooled when a highly optimized, nonvendor short-echo, single-voxel proton MRS pulse sequence is used in conjunction with identical calibration and quantification procedures. MethodsA modified semi-LASER sequence (T-E = 28 ms) was used to acquire spectra from two brain regions (cerebellar vermis and pons) on two Siemens 3T scanners using the same B-0 and B-1 calibration protocols from two different cohorts of healthy volunteers (N = 24-33 per site) matched for age and body mass index. Spectra were quantified with LCModel using water scaling. ResultsThe spectral quality was very consistent between the two sites and allowed reliable quantification of at least 13 metabolites in the vermis and pons compared with 3-5 metabolites in prior multisite magnetic resonance spectroscopy trials using vendor-provided sequences. The neurochemical profiles were nearly identical at the two sites and showed the feasibility to detect interindividual differences in the healthy brain. ConclusionHighly reproducible neurochemical profiles can be obtained on different clinical 3T scanners at different sites, provided that the same, optimized acquisition and analysis techniques are used. This will allow pooling of multisite data in clinical studies, which is particularly critical for rare neurological diseases. Magn Reson Med 73:1718-1725, 2015. (c) 2014 Wiley Periodicals, Inc.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.5
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available